KPV

KPV (Lys-Pro-Val) is a synthetic tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH), studied in controlled laboratory environments for its interaction with inflammatory signaling pathways and immune regulatory models. In experimental research settings, KPV has been investigated for its potential influence on cytokine-associated transcriptional frameworks, NF-κB pathway signaling systems, and peptide-mediated intracellular communication networks. Due to its short-chain peptide structure and targeted molecular profile, it remains a compound of interest in immunology and cellular signaling research domains. Preclinical investigations have examined KPV for its involvement in epithelial barrier research models, macrophage-associated regulatory pathways, and chromatin-associated gene expression frameworks. Ongoing scientific studies continue to evaluate its molecular stability, receptor-mediated signaling characteristics, and downstream intracellular responses within strictly controlled laboratory conditions focused on inflammatory and immune research. This research-grade KPV peptide (10mg) is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural consistency. KPV is intended strictly for laboratory research and analytical purposes only and is not for human consumption.